BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Business

  Cytokinetics, Inc. to Announce First Quarter Results on April 30, 2009

  April 24, 2009

   · 

  3 min read
• Drug Development

  Bristol-Myers Squibb Company and ZymoGenetics, Inc. Present Positive 4-week Results of PEG-Interferon lambda with Ribavirin in Hepatitis C

  April 24, 2009

   · 

  6 min read
• Lone Star Bio

  Amarillo Biosciences Supplies Oral Interferon for Taiwanese Hepatitis C Study

  April 24, 2009

   · 

  3 min read
• Business

  Neovasc Inc. Reports Year 2008 Financial Results

  April 24, 2009

   · 

  9 min read
• BioForest

  BioMS Medical to Present at BioFinance 2009

  April 24, 2009

   · 

  2 min read
• Drug Development

  OctoPlus’ Licensee Biolex Therapeutics Presents Locteron Phase IIa Results at EASL Conference

  April 24, 2009

   · 

  5 min read
• Business

  Labopharm Announces Details for First Quarter Results Conference Call and Annual Meeting

  April 24, 2009

   · 

  2 min read
• Pharm Country

  Wyeth Declares Common and Preferred Stock Dividends

  April 24, 2009

   · 

  1 min read
• Biotech Bay

  PercSys Introduces Accordion CoAx(TM) Stone Control Device for Facilitating Percutaneous Kidney Stone Treatments

  April 24, 2009

   · 

  3 min read
• Crucell N.V. Announces Release of 2008 Annual Report and Form 20-F

  April 24, 2009

   · 

  2 min read